On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

Bayer also recently submitted gadoquatrane for approval in Japan. The company plans to submit further regulatory applications to health authorities worldwide in the coming months, it said.

AI reveals hidden language patterns and likely authorship in the Bible by Duke University edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...

Real Madrid are reportedly mulling over scuppering Bayer Leverkusen’s plans to sign an ideal replacement for Liverpool-bound Florian Wirtz. With Xabi Alonso getting confirmed as Madrid’s new ...

Investing.com -- Shares of Bayer AG (ETR: BAYGN) were up over 5% on Thursday after Goldman Sachs upgraded the German pharmaceutical and life sciences company to a "buy" rating from "neutral." ...

U.S. ambassador says Canadians facing device searches, detainment ’not a pattern’ Canadian Press Dylan Robertson Published Jun 07, 2025 • 3 minute read ...

Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation ...

Liverpool remain locked in talks with Bayer Leverkusen over a club-record deal for Florian Wirtz. The Reds’ latest offer was worth an overall £113m, but the Bundesliga outfit are holding out ...